These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

426 related items for PubMed ID: 10688973

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist.
    Ozaki S, Kawamoto H, Itoh Y, Miyaji M, Azuma T, Ichikawa D, Nambu H, Iguchi T, Iwasawa Y, Ohta H.
    Eur J Pharmacol; 2000 Aug 18; 402(1-2):45-53. PubMed ID: 10940356
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Nociceptin (orphanin FQ): high-affinity and high-capacity binding site coupled to low-potency stimulation of guanylyl-5'-O-(gamma-thio)-triphosphate binding in rat brain membranes.
    Albrecht E, Samovilova NN, Oswald S, Baeger I, Berger H.
    J Pharmacol Exp Ther; 1998 Aug 18; 286(2):896-902. PubMed ID: 9694948
    [Abstract] [Full Text] [Related]

  • 9. G protein activation and cyclic AMP modulation by naloxone benzoylhydrazone in distinct layers of rat olfactory bulb.
    Onali P, Olianas MC.
    Br J Pharmacol; 2004 Nov 18; 143(5):638-48. PubMed ID: 15451772
    [Abstract] [Full Text] [Related]

  • 10. Replacement of Gln280 by His in TM6 of the human ORL1 receptor increases affinity but reduces intrinsic activity of opioids.
    Mollereau C, Moisand C, Butour JL, Parmentier M, Meunier JC.
    FEBS Lett; 1996 Oct 14; 395(1):17-21. PubMed ID: 8849681
    [Abstract] [Full Text] [Related]

  • 11. [Nphe(1)]NC(1-13)NH(2) selectively antagonizes nociceptin/orphanin FQ-stimulated G-protein activation in rat brain.
    Berger H, Calo' G, Albrecht E, Guerrini R, Bienert M.
    J Pharmacol Exp Ther; 2000 Aug 14; 294(2):428-33. PubMed ID: 10900215
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Comparison of the in vitro efficacy of mu, delta, kappa and ORL1 receptor agonists and non-selective opioid agonists in dog brain membranes.
    Lester PA, Traynor JR.
    Brain Res; 2006 Feb 16; 1073-1074():290-6. PubMed ID: 16443205
    [Abstract] [Full Text] [Related]

  • 14. Recognition and activation of the opioid receptor-like ORL 1 receptor by nociceptin, nociceptin analogs and opioids.
    Butour JL, Moisand C, Mazarguil H, Mollereau C, Meunier JC.
    Eur J Pharmacol; 1997 Feb 19; 321(1):97-103. PubMed ID: 9083791
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Phe1phi(CH2-NH)Gly2]nociceptin-(1-13)-NH2 acts as a partial agonist at ORL1 receptor endogenously expressed in mouse N1E-115 neuroblastoma cells.
    Olianas MC, Maullu C, Ingianni A, Onali P.
    Neuroreport; 1999 Apr 06; 10(5):1127-31. PubMed ID: 10321496
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.